Drug Combination Details
| General Information of the Combination (ID: C65108) | |||||
|---|---|---|---|---|---|
| Name | Peginterferon alpha 2b NP Info | + | S-1 Drug Info | ||
| Disease |
Hepatocellular carcinoma
[ICD-11: 2C12]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| Experimental
Result(s) |
Combination therapy with S-1 and PEG-IFN is effective and feasible, and is therefore a promising regimen for advanced HCC. | |||||
| References | ||||
|---|---|---|---|---|
| Reference 1 | Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma. Oncology. 2008;75 Suppl 1:106-13. | |||
